When designing a clinical trial or study, the value of the following i
nterrelated parameters should be determined prior to collecting data:
clinical significance, statistical significance, power, and sample siz
e. Too often, clinical importance and the other design issues are igno
red and only statistical significance dictates the conclusions of the
study. In order to evaluate the frequency that each of these design pa
rameters is addressed in the published literature, the topic of pulmon
ary function tests (specifically forced vital capacity) was chosen, an
d all relevant articles for one year (1990) were identified using Minn
esota MEDLINE. A total of 121 articles met the selection criteria and
were reviewed. Of all the articles, 13.2% discussed clinical significa
nce, 21.5% discussed sample size, and only 5.0% addressed statistical
power. As expected, the majority of the articles (92.6%) discussed sta
tistical significance (P values). None of the articles mentioned all f
our factors. When choosing the level of clinical significance several
methods may be used. Such might be well established in certain clinica
l areas or available from previous publications and references or they
may be attainable from pilot study data and, in the absence of any pr
ior information, a clinician may use personal experience. To minimize
subjectivity, the clinical effect-size can be based on the population
distribution of the measurement of interest. (C) 1993 Wiley-Liss, Inc.